The use of erythropoietin in cardiac arrest victims: the impact on survival and neurological outcome

Completed

• Conditions: Cardiac arrest; Circulatory System

• Registration Number: ISRCTN67856342
• Lead Sponsor: Centre for Health and Emergency Medicine (Zdravstveni dom adolfa drolca maribor) (Slovenia)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2007-07-20
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

1. 18 years or older
2. Non-traumatic, cardiac arrest in pre-hospital setting when started with cardiopulmonary reanimation irrespective of initial cardiac rhythm

Exclusion Criteria

1. Traumatic cardiac arrest
2. Under 18 years of age
3. Cardiopulmonary Resuscitation (CPR) without drugs (only defibrillation)
4. Pregnancy
5. Severe hypothermia (<30°C)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
eurological outcome assessed by CPC, from CPC-1 (normal neorological status) to CPC-5 (brain death). This will be measured six months after cardiopulmonary resuscitation.

Secondary Outcome Measures

Name	Time	Method
1. ROSC in the field (%)<br>2. ROSC with admission to hospital<br>3. 24-hour survival <br>4. Survival (discharge from hospital)